Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV [Phase 1]

View source ↗

Summary

NIH/NIAID-sponsored Phase 1 trial evaluating the safety and immunogenicity of V3-region directed immunogens DV700P-RNA followed by DV701B1.1-RNA in adults witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DV700P-RNA
• DV701B1.1-RNA

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV-1-infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING